Évaluation de la santé osseuse dans la population générale, en ostéoporose et en insuffisance rénale chronique

Khelifi, Nada; Caron-Dorval, Dominique; Mac-Way, Fabrice

doi:https://doi.org/10.7202/1062452ar

1. Bilezikian JP, Bouillon R, Clemens T, Compston J. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. In: Bilezikian JP, ed. Ninth ed. United States of America, 2018.

Google Scholar

2. Li J, Bao Q, Chen S, et al. Different bone remodeling levels of trabecular and cortical bone in response to changes in Wnt/beta-catenin signaling in mice. Journal of orthopaedic research: official publication of the Orthopaedic Research Society. 2017;35(4):812-819.

10.1002/jor.23339 Google Scholar

3. Bisson SK, Ung RV, Mac-Way F. Role of the Wnt/beta-Catenin Pathway in Renal Osteodystrophy. Int J Endocrinol. 2018;2018:5893514.

Google Scholar

4. Krishnan V, Bryant HU, Macdougald OA. Regulation of bone mass by Wnt signaling. The Journal of clinical investigation. 2006;116(5):1202-1209.

10.1172/JCI28551 Google Scholar

5. Fernandes TAP, Goncalves LML, Brito JAA. Relationships between Bone Turnover and Energy Metabolism. Journal of diabetes research. 2017;2017:9021314.

10.1155/2017/9021314 Google Scholar

6. Marsot C, Chanson P, Borson-Chazot F. [Bone and metabolism]. Annales d’endocrinologie. 2018;79 Suppl 1:S40-s47.

10.1016/S0003-4266(18)31236-8 Google Scholar

7. Santos L, Elliott-Sale KJ, Sale C. Exercise and bone health across the lifespan. Biogerontology. 2017;18(6):931-946.

10.1007/s10522-017-9732-6 Google Scholar

8. Hendrickx G, Boudin E, Van Hul W. A look behind the scenes: the risk and pathogenesis of primary osteoporosis. Nature reviews. Rheumatology. 2015;11(8):462-474.

Google Scholar

9. Flynn A. The role of dietary calcium in bone health. The Proceedings of the Nutrition Society. 2003;62(4):851-858.

10.1079/PNS2003301 Google Scholar

10. Bachrach LK. Acquisition of optimal bone mass in childhood and adolescence. Trends in endocrinology and metabolism: TEM. 2001;12(1):22-28.

10.1016/S1043-2760(00)00336-2 Google Scholar

11. Hopkins RB, Burke N, Von Keyserlingk C, et al. The current economic burden of illness of osteoporosis in Canada. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2016;27(10):3023-3032.

10.1007/s00198-016-3631-6 Google Scholar

12. Ensrud KE, Crandall CJ. Osteoporosis. Annals of internal medicine. 2017;167(3):Itc17-itc32.

10.7326/AITC201708010 Google Scholar

13. Osteoporosis prevention, diagnosis, and therapy. Jama. 2001;285(6):785-795.

10.1001/jama.285.6.785 Google Scholar

14. Kanis JA, Oden A, Johnell O, Jonsson B, de Laet C, Dawson A. The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2001;12(5):417-427.

10.1007/s001980170112 Google Scholar

15. Bessette L, Ste-Marie LG, Jean S, et al. The care gap in diagnosis and treatment of women with a fragility fracture. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2008;19(1):79-86.

10.1007/s00198-007-0426-9 Google Scholar

16. Osteoporosis Canada. Impact Report 2017. https://osteoporosis.ca/wp-content/themes/osteo/theme/img/impact-report/impact-report-2017-en.pdf.

Google Scholar

17. Golob AL, Laya MB. Osteoporosis: screening, prevention, and management. The Medical clinics of North America. 2015;99(3):587-606.

10.1016/j.mcna.2015.01.010 Google Scholar

18. V Nguyen T, A Eisman J. Chapter 29 - Individualized Prognosis of Fracture in Men. In: Orwoll ES, Bilezikian JP, Vanderschueren D, eds. Osteoporosis in Men (Second Edition). San Diego: Academic Press; 2010:361-373.

10.1016/B978-0-12-374602-3.00029-8 Google Scholar

19. Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. American journal of obstetrics and gynecology. 2006;194(2 Suppl):S3-11.

10.1016/j.ajog.2005.08.047 Google Scholar

20. Papaioannou A, Morin S, Cheung AM, et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ: Canadian Medical Association journal = journal de l’Association médicale canadienne. 2010;182(17):1864-1873.

10.1503/cmaj.100771 Google Scholar

21. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organization technical report series. 1994;843:1-129.

Google Scholar

22. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ (Clinical research ed.). 1996;312(7041):1254-1259.

Google Scholar

23. Cummings SR, Bates D, Black DM. Clinical use of bone densitometry: scientific review. Jama. 2002;288(15):1889-1897.

10.1001/jama.288.15.1889 Google Scholar

24. Leslie WD, Berger C, Langsetmo L, et al. Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2011;22(6):1873-1883.

10.1007/s00198-010-1445-5 Google Scholar

25. Rotondi NK, Beaton DE, Elliot-Gibson V, et al. Comparison of CAROC and FRAX in Fragility Fracture Patients: Agreement, Clinical Utility, and Implications for Clinical Practice. The Journal of rheumatology. 2016;43(8):1593-1599.

10.3899/jrheum.151409 Google Scholar

26. Kanis JA, Harvey NC, Johansson H, Oden A, Leslie WD, McCloskey EV. FRAX Update. Journal of clinical densitometry: the official journal of the International Society for Clinical Densitometry. 2017;20(3):360-367.

10.1016/j.jocd.2017.06.022 Google Scholar

27. Unnanuntana A, Gladnick BP, Donnelly E, Lane JM. The assessment of fracture risk. The Journal of bone and joint surgery. American volume. 2010;92(3):743-753.

Google Scholar

28. Brown JP, Albert C, Nassar BA, et al. Bone turnover markers in the management of postmenopausal osteoporosis. Clinical biochemistry. 2009;42(10-11):929-942.

10.1016/j.clinbiochem.2009.04.001 Google Scholar

29. Levin A, Hemmelgarn B, Culleton B, et al. Guidelines for the management of chronic kidney disease. CMAJ: Canadian Medical Association journal = journal de l’Association médicale canadienne. 2008;179(11):1154-1162.

10.1503/cmaj.080351 Google Scholar

30. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney international supplements. 2017;7(1):1-59.

10.1016/j.kisu.2017.04.001 Google Scholar

31. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney international. Supplement. 2009(113):S1-130.

Google Scholar

32. Mac Way F, Lessard M, Lafage-Proust MH. Pathophysiology of chronic kidney disease-mineral and bone disorder. Joint, bone, spine: revue du rhumatisme. 2012;79(6):544-549.

10.1016/j.jbspin.2012.09.014 Google Scholar

33. Damasiewicz MJ, Nickolas TL. Rethinking Bone Disease in Kidney Disease. JBMR plus. 2018;2(6):309-322.

10.1002/jbm4.10117 Google Scholar

34. Bowling CB, Muntner P. Epidemiology of chronic kidney disease among older adults: a focus on the oldest old. The journals of gerontology. Series A, Biological sciences and medical sciences. 2012;67(12):1379-1386.

Google Scholar

35. Carvalho C, Alves CM, Frazao JM. The role of bone biopsy for the diagnosis of renal osteodystrophy: a short overview and future perspectives. Journal of nephrology. 2016;29(5):617-626.

10.1007/s40620-016-0339-9 Google Scholar

36. Evenepoel P, Behets GJS, Laurent MR, D’Haese PC. Update on the role of bone biopsy in the management of patients with CKD-MBD. Journal of nephrology. 2017;30(5):645-652.

10.1007/s40620-017-0424-8 Google Scholar

37. Patel L, Bernard LM, Elder GJ. Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials. Clinical journal of the American Society of Nephrology: CJASN. 2016;11(2):232-244.

10.2215/CJN.06800615 Google Scholar

38. Ketteler M, Block GA, Evenepoel P, et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters. Kidney Int. 2017;92(1):26-36.

10.1016/j.kint.2017.04.006 Google Scholar

Parties annexes

Bibliographie

Outils de citation

Citer cet article

Exporter la notice de cet article